CheckMate 9LA: broadening treatment options for patients with non-small-cell lung cancer.

Passaro, Antonio; Attili, Ilaria; de Marinis, Filippo

Passaro, Antonio; Attili, Ilaria; de Marinis, Filippo.

Affiliation

Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy. Electronic address: antonio.passaro@ieo.it.
Attili I; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy.
de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy.

Lancet Oncol ; 22(2): 157-159, 2021 02.

Article in En | MEDLINE | ID: mdl-33476592

Subject(s)

Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Agents, Immunological/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Humans; Ipilimumab/therapeutic use; Lung Neoplasms/drug therapy; Nivolumab/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google